1 Tada H,Shiho O,Kuroshima K,et al.An improved colorimetric assay for interleukin-2. J Immunol Methods,1986,93:157
2 Misnabb T.Rapid colormetric assay for cellular growth and survil:application to proliferation and cytotoxicity assay. J Immunol Methods,1983,65:55
3 Campling BG,PymJ,Baker HM,et al. Chemosen-sitivity testing of small cell lung cancer using the MTT assay. Br J Cancer,1991,63:75
4 Sladonski D,Steer SJ,Clolhier RH,et al.An improved MTT assay. J. lmmunol Metheds,1993,157:203
5 黄永年,李薇.噻唑蓝比色法实验条件的研究.中华医学检验杂志,1992,15(4):229
6 孙缵耀,郭庆福,庄汉澜.两种检测细胞活性的改良MTT法.军事医学科学院刊,1993,17(1):61
7 Hansen MB,Nielsen SE,Berg K.Re-examination and further development of a precise and repid dye method for measuring cell growth/ cell kill. J Immunol Methods,1986,119:203
8 Carmichael J.Evaluation of a rerazolium-based semiautomated colorimetric assay:assessment of chemosensivity testing. Cancer Res. 1987. 47:936
9 关慧贞,匡彦德,秦慧莲.等.四种检测白细胞介素-2(IL-2)方法的比较.上海免疫学杂志,1986,6(5):298
10 Gills,Smith Ka.T-cell growth factor:Parameters of prodution and a quantative microasay for acivit. J Immunol,1978,120:2027
11 Ohno M,Abe T.Rapid colorimetic assay for the quantification of leukemia inhibitory facoteLLI) and inter leukin-6IL1-6). J Immunol Methods,1919145.199
12 Espevid T,Meyer JN.A highly sensitive cellline,WEHI164 Clone 13,for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods,1986,95:99
13 Stevens MG,Olsen SC.Comparative analysis of using neutrophil bactericidal activity. J Immuno! Methods,1993,157:225
14 Stevens MG,Kehrli ME,Canning IC.A colorimetric assay for quantitating boving neutrophs bacterici-dal activity. Vet Immunol Immunopathol,1991,28:45
15 Thomas M,Buttke,James A,el al. aqueous soluble tetrazolium/ formazan assay to measure viability and proliferation of lymphokine一dependent celllines. J Immunol Methods,1993,157:233
16 Svirshchevskays EV,Sidorov LA,Viskova NY,el al. Quantitative analysis of interleukin-2-induced proliferation in the presence of inhibitors using anathematical model. J lmmunol Methods,1993,159:17

[1]	CAO Xuefen, LENG Yufang, HAN Xiaoxia, HOU Xiaoyu, LYU Xingjiao, Janvier NIBARUTA. Tetramethylpyrazine protected against intestinal ischemia-reperfusion injury induced pyroptosis by inhibiting NLRP3 inflammasome activation [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1201-1208.
[2]	WANG Jian, SUN Yongdong, ZHOU Xingwei, LIU Lei, CHEN Long, TONG Xingke, ZHU Jiali. Baicalein promotes laryngeal cancer cell death and inhibits invasion via miR-125b-5p/IRF4 axis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1209-1218.
[3]	ZHU Ruifang, GUO Dongkai, ZHI Hui, JIANG Yiguo, ZHANG Yueling, QIAN Xiaoping, JI Shiliang. Exploring the mechanism of elemene synergistic bortezomib against multiple myeloma by ROS-NF-κB-p38MAPK pathway [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1219-1226.
[4]	LI Fei, DING Huiqin, CHEN Mengjing. Isonlosinine induces autophagy of PC9 cells by ERK signaling pathway in lung cancer [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1235-1240.
[5]	SHI Dandan, SUN Yiyao, CHEN Xiaoqi, YANG Fangming, ZHANG Chuanlei, WANG Xinting, YUAN Changwei, CHEN Xinju. Curative effect of fuzheng xiaoliu granules in the treatment of primary liver cancer and analysis of serum metabolomics [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1247-1262.
[6]	CHEN Yulin, JIANG Hugang, WANG Xinqiang, LIU Kai, LI Yingdong, AN Tao, ZHAO Xinke. Effects and mechanism of Ginseng Yixin granules (QSYXG) for heart failure with preserved ejection fraction based on the network pharmacology and molecular docking strategy [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1081-1092.
[7]	WANG Xiu, JI Qilin, PEI Wenjun, ZENG Ying. 3-bromopyruvate cholesterol ester enhances the sensitivity of breast cancer cells to tamoxifen [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1093-1100.
[8]	HENG Bingbing, YANG Danfeng, DAI Shuyang, SHANGGUAN Wangning. Propofol relieves the subcutaneous chloroquine-induced pruritus in rats via TRPV1 and CB1 receptors of spinal cord [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1101-1108.
[9]	LIAO Mengling, WANG Yan, LUO Jing, WANG Nuoyan, HUA Ling, ZHANG Yu, DENG Fei, YUAN Yue, ZHOU Jun, ZHOU Hong. Molecular mechanism of artesunate attenuates the release of proinflammatory cytokines from macrophages [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 969-978.
[10]	YOU Rongli, HUANG Yurong, MAORui, HAI Lina, WANG Yingli, WANG Yan. Mechanism of compound kushen injection in the treatment of lung cancer based on serum metabolomics and network pharmacology [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 988-999.
[11]	WANG Ruyue, XIE Fei, WANG Xin, LI Hongyu. Therapeutic effect of lienal polypeptide injection on bone marrow suppression and immunodeficiency in KM mice following chemotherapy [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1000-1007.
[12]	MAO Jun, RONG Yu, LI Yangen, XIONG Dengxi, ZHAO Peng, ZHA Zhengjiang. Effect and safety of flurbiprofen axetil in the analgesic treatment of patients with craniocerebral injury [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1056-1060.
[13]	MA Xiankang, YANG Lixia, CUI Yangyang, MI Denghai. Angelica polysaccharides improve hepatic endoplasmic reticulum stress by inhibiting the expression of GRP78, p-PERK and p-Eif2α in diabetic KK-Ay mice [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 926-936.
[14]	WANG Kun, XU Peipei, ZHOU Lanlan, LU Sheng. Mechanism of neuroprotective effect of ginsenoside Rg1 regulating Epac1/Rap1 signaling pathway in rats with ischemic stroke [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 721-727.
[15]	LI Shixu, LI Linyun, WANG Xin, LI Ke, BIAN Hua. Effects of Ginkgo biloba extract on renal injury in rats with experimental renal failure through miR-145/FOXO1 axis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 728-735.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments